← Human Trials & Peer-Reviewed Studies
Depot goserelin and danazol pre-treatment before rollerball endometrial ablation for menorrhagia
Plain-language guide to PMID 8602306 (1996): randomized controlled trial study of Goserelin, endometriosis.
Key Facts
- PMID
- 8602306
- Journal
- Obstetrics and gynecology
- Year
- 1996
- Study type
- Randomized Controlled Trial
- Authors
- Fraser IS et al. (6 authors)
- DOI
- 10.1016/0029-7844(95)00475-0
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial paper looks at Goserelin in the context of endometriosis.
Who Took Part
PubMed tags the participants as women only.
The researchers performed an open, randomized study of women with clinically convincing histories of menorrhagia.
How the Study Was Run
The researchers set it up as a randomized study.
Because people in this Goserelin study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
What Was Measured
The subject headings attached to it are Combined Modality Therapy, Danazol, Endometrium, Estrogen Antagonists, Goserelin, Laser Coagulation and Menorrhagia.
What This Means in Plain Language
The paper is a randomized study of Goserelin in people with endometriosis.
Results are reported in around 8 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 1996 (Obstetrics and gynecology), a journal based in United States.
More context: the Goserelin compound page, Endometriosis research.
Our Notes on the Compound
Goserelin: A GnRH analog implant (Zoladex) used to lower sex-hormone levels in prostate and breast cancer and gynecologic conditions.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.